High plasma-GFAP levels in metastatic myxopapillary ependymoma
- 242 Downloads
Myxopapillary ependymoma (MPE) is a rare tumor of the distal spinal cord. Despite benign histopathology, local recurrences occur in ~30 % of patients and distant metastases have been described in few cases. MPE tumor cells typically express glial fibrillary acidic protein (GFAP), which could be released to the circulation. In this current report, we investigated circulating plasma-GFAP in a series of MPE patients. We analyzed circulating plasma-GFAP using a commercially available ELISA kit in 3 patients with completely resected MPE, 1 patient with locally advanced MPE and 2 patients with pleuropulmonary metastases of MPE. As controls we used blood samples of age and gender-matched healthy volunteers (n = 3), 6 glioblastoma patients with known plasma-GFAP status (positive for 3 and negative for 3 patients) and 3 brain metastases patients with known plasma-GFAP negativity. We found very high concentrations of plasma-GFAP in two MPE patients with pleuropulmonary metastases, while in none of the other MPE patients circulating plasma-GFAP was detectable. Circulating GFAP could be useful as marker for early detection or follow-up of distant metastases in MPE patients.
KeywordsMyxopapillary ependymoma GFAP Plasma Pleuropulmonary metastases Glioblastoma
We thank all patients and our colleagues Dr. Roland Hansen (Aachen, Germany) and Dr. Mila Petrova (Sofia, Bulgaria) for their support and cooperation.
Conflict of interest
The authors declare no conflict of interest with regard to the content of the manuscript.
- 4.Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, Raabe A, Neumann-Haefelin T, Steinmetz H, Sitzer M (2006) Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 77:181–184PubMedCrossRefGoogle Scholar
- 9.Louis DN, Ohgaki H, Wiestler O, Cavenee W (2007) WHO classification of tumours of the central nervous system, 4th edn. Blackwell, OxfordGoogle Scholar
- 12.Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, Ozyigit G, Baumert BG, Zaucha R, Haller G, Weber DC (2009) The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 74:1114–1120PubMedCrossRefGoogle Scholar
- 13.Weber DC, Li J, Miller R, Villa S, Anacak Y, Poortmans P, Baumert B, Pica A, Ozyigit G, Preusser M (2012) Outcome of patients with primary spinal myxopapillary ependyomama: a retrospective study from the MD Anderson Cancer Center and Rare Cancer Network. EANO 10th meeting, Marseille/France, September 2012Google Scholar